Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17376007 | 0.93 | L3MBTL1 (0.32) | L3MBTL1ALDH1A1LMNA | |
| SCHEMBL17376021 | 0.90 | L3MBTL1 (0.31) | L3MBTL1TSHRCYP2C19 | |
| SCHEMBL80816 | 0.90 | L3MBTL1 (0.31) | L3MBTL1TSHRCYP2C19 | |
| SCHEMBL17376013 | 0.90 | L3MBTL1 (0.31) | L3MBTL1TSHRCYP2C19 | |
| SCHEMBL14421044 | 0.88 | — | — | |
| SCHEMBL782161 | 0.86 | — | — | |
| SCHEMBL16424463 | 0.86 | ALDH1A1 (0.36) | L3MBTL1ALDH1A1LMNA | |
| Ammonia Solution, Strong SCHEMBL10792221 | 0.83 | ALDH1A1 (0.33) | ALDH1A1LMNA | |
| SCHEMBL4993236 | 0.79 | — | — | |
| SCHEMBL17691528 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630677-B2 | Resin suitable for three-dimensional printing | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20240294712-A1 | RESIN SUITABLE FOR THREE-DIMENSIONAL PRINTING | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2024-09-05 | — | — | US | disclosed |
| US-12006401-B2 | Resin suitable for three-dimensional printing | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2024-06-11 | — | — | US | disclosed |
| EP-3157971-B1 | URETHANE ACRYLATE POLYMERS WITH UNIQUE PHYSICAL PROPERTIES | ARKEMA FRANCE (FR) | 2023-08-09 | — | — | EP | disclosed |
| US-20220325049-A1 | RESIN SUITABLE FOR THREE-DIMENSIONAL PRINTING | JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) | 2022-10-13 | — | — | US | disclosed |
| US-20170158803-A1 | URETHANE ACRYLIC POLYMERS WITH UNIQUE PHYSICAL PROPERTIES | ARKEMA FRANCE (FR) | 2017-06-08 | — | — | US | disclosed |
| EP-3157971-A1 | URETHANE ACRYLATE POLYMERS WITH UNIQUE PHYSICAL PROPERTIES | Arkema France (FR) | 2017-04-26 | — | — | EP | disclosed |
| WO-2015198493-A1 | URETHANE ACRYLATE POLYMERS WITH UNIQUE PHYSICAL PROPERTIES | ARKEMA FRANCE (FR) | 2015-12-30 | — | — | WO | disclosed |
| EP-0402408-A4 | SOLVENT RESISTANT IRRADIATION CURABLE COATINGS | — | 1992-05-13 | — | — | EP | disclosed |
| EP-0402408-A1 | SOLVENT RESISTANT IRRADIATION CURABLE COATINGS | GAF CHEMICALS CORPORATION (US) | 1990-12-19 | — | — | EP | disclosed |
| US-4885319-A | DIVINYL ETHERS USED AS REACTIVE DILUENT FOR EPOXY RESINS | GAF CORPORATION (US) | 1989-12-05 | — | — | US | disclosed |
| WO-1989007986-A1 | SOLVENT RESISTANT IRRADIATION CURABLE COATINGS | GAF CHEMICALS CORPORATION (US) | 1989-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630677-B2 | Resin suitable for three-dimensional printing | HTR3D, CAD, SMCHD1 | L3MBTL1 3391/4885ALDH1A1 843/4885LMNA 2651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.